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and Vittorio Fineschi1*Abstract
This case report describes a sudden cardiac death in an apparent healthy 11-month-old infant caused by a
multifocal cardiac rhabdomyoma. Parents reported that a few days before the child had fallen to the ground
getting a little superficial injury to the scalp. The authors hypothesize that it may have been a transient loss of
consciousness episode caused by the cardiac tumour. After the gross examination, histological investigation
supported by immunohistochemical analysis using antibody anti- Myoglobin, Actin, Vimentin, Desmin, CD34,
S-100, Ki-67 was carried out for the diagnosis. Death was attributed to a multifocal cardiac rhabdomyoma, a
benign tumour of striated muscle, which has been completely asymptomatic. In particular, one mass filled the
entire posterior wall of the left ventricle. The insidious development of benign cardiac tumours also in infants
and children is outlined, focusing on the responsible mechanisms of sudden death in such cases and providing
a reference for additional study on these subjects.
Virtual slides: The virtual slide(s) for this article can be found here:
http://www.diagnosticpathology.diagnomx.eu/vs/7163626988365078
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Cardiac tumours can be divided into primary and sec-
ondary; the first ones occur infrequently both in adult
and paediatric age groups. In the general population,
their incidence ranges between 0.001% and 0.030% in
unselected autopsy series; approximately 75% of primary
cardiac tumours are benign, and 25% are malignant [1].
In adults the most common ones are myxomas.
In the paediatric population, cardiac tumours are
reported with a frequency of 0.02% to 0.04% [2,3]. Usu-
ally they are benign, with minimal growth potential, but
a minor portion can become quite large, compressing
the cardiac chambers or the vital structures such as* Correspondence: vfinesc@tin.it
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reproduction in any medium, provided the orconduction tissue or coronary blood vessels, as well as
obstructing the cardiac valves and the outflow tracts.
Most paediatric cardiac tumours are considered be-
nign; however, the development of hemodynamic im-
pairment or malignant arrhythmias may complicate the
management of these tumours in some patients. In par-
ticular, malignant arrhythmias increase the risk of sud-
den cardiac death [4]. In the absence of these
complications, observation is the standard care in most
cases because many tumours spontaneously regress with
time.
We report the case of a sudden cardiac death of a 11-
month-old female infant with a primary multicentric left
ventricle tumour. Histological and immunohistochemical
studies allowed to make the diagnosis of rhabdomyoma
and to define the mechanism inducing sudden death.
This report outlines the importance of studies per-
formed during the third trimester of pregnancy for early. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cally benign, may be life-threatening for the arrhythmo-
genic potential they display.
Case presentation
A mother was bathing her 11-month-old baby, but sud-
denly the infant showed a worsening dyspnoea. Parents
accompanied the baby to the emergency room immedi-
ately, but despite the resuscitative manoeuvres, the doc-
tor could only pronounce the death. The familiar history
was negative for sudden death. Also the obstetric, re-
mote and recent pathological anamneses were negative,
except for a referred unexplained fall dating back to two
days before.
A complete post-mortem examination was performed
within 48 hours after death. The body was that of a regu-
larly developed 11-month old infant. External examin-
ation was insignificant, except for the presence of a little
and superficial iatrogenic wound on the sternal region.
The internal examination revealed a peduncolated
4,5 × 3 × 2 cm mass at the cardiac apex, a second super-
ficial subepicardial 2 × 1,5 × 1 cm neoformation on the
posterior wall of the left ventricle and a third transmural
1 × 1,2 × 1,4 cm nodule on the posterior wall of the left
ventricle (Figure 1). Polyvisceral congestion, cerebral and
pulmonary oedema, with a massive increase in lung
weight were also evident.
The histological examination of cardiac specimens,
stained with haematoxylin–eosin, Masson and PTAH
showed a demarcation and separation of the three
masses from the surrounding regular parenchyma. TheFigure 1 Microscopic findings. The peduncolated mass at the cardiac ap
neoformation on the posterior wall of the left ventricle, measured 2 × 1,5 ×striated muscle cells appeared diffusely vacuolated,
enlarged, with round to oval slightly irregular nuclei and
variable cytoplasmatic clearing. There were occasional
spider cells. Small residues of muscular tissue entrapped
in the masses were also visible.
In addition an immunohistochemical investigation of
cardiac tissue samples was performed utilizing anti-
bodies anti-Myoglobin, Actin, Vimentin, Desmin, CD 34,
Ki67 and S100 (DAKO, Copenhagen, Denmark). For this
study, we used 4 μm-thick paraffin sections mounted on
slides covered with 3, aminopropyltriethoxysilane (Fluka,
Buchs, Switzerland). Pre-treatment was necessary to fa-
cilitate antigen retrieval and to increase membrane per-
meability to antibodies anti-CD 34 boiling in 0.25 M
EDTA buffer, to antibodies anti-Ki67 boiling in 0.1 M
Citric Acid buffer, to antibody anti-S100 for 15 min in
Proteolytic Enzyme (Dako, Copenhagen, Denmark), at
20°C. For antibody anti- Myoglobin, Actin, Vimentin,
Desmin it wasn’t necessary a pre-treatment for antigen
retrieval. The primary antibody was applied in 1:300
ratio for S100, in 1:50 ratio for CD 34, Desmin and
Vimentin, in 1:2000 ratio for Actin, in 1:6000 ratio for
Myoglobin, in 1:100 ratio for Ki67 and incubated for 120
min at 20°C. The detection system utilized was the
LSAB+ kit (Dako, Copenhagen, Denmark), a refined
avidin-biotin technique in which a biotinylated second-
ary antibody reacts with several peroxidase-conjugated
streptavidin molecules. The sections were counter-
stained with Mayer’s haematoxylin, dehydrated, cover
slipped and observed in a Leica DM4000B optical micro-
scope (Leica, Cambridge, UK).ex measured 4,5 × 3 × 2cm (A). A second superficial subepicardial
1cm (B).
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positive reaction for antibodies anti-Myoglobin, Actin,
Vimentin, Desmin, CD34; while reaction for antibodies
Anti-Ki67 and Anti-S100 was negative (Figures 2–3).
These results of the immunohistochemical analysis were
consistent with the diagnosis of rhabdomyoma.
Toxicological screening resulted negative. There were
no signs of tuberous sclerosis.
It was concluded that the sudden cardiac death of the
infant was attributable to the multifocal primary cardiac
tumour, the rhabdomyoma, consisting in three cardiac
lesions. In particular one tumoral mass occupied almost
the whole posterior wall of the left ventricle, rising from
the apex to the valvular level, so compromising the regu-
lar contraction of the left ventricle. The neoplasms prob-
ably have caused two days before a near syncopal
episode that the parents erroneously referred as a fall.Conclusions
Cardiac tumours are infrequent clinical entities both in
adult and paediatric age groups; they can be divided into
primary and secondary; approximately 75% of primary
cardiac tumours are benign, and 25% are malignant [1].
The occurrence of metastatic cardiac tumours has been
reported 100-fold more commonly than primary lesions.
Approximately half of benign cardiac tumours in adults
are myxomas, and the rest are lipomas, papillary fibroe-
lastomas, and rhabdomyomas. Among malignant pri-
mary cardiac tumours, the most reported are those
histopathologically considered as undifferentiated, fol-
lowed by angiosarcomas and leiomyosarcomas.Figure 2 Microscopic findings. (A) Demarcation and separation of the tu
of muscular tissue entrapped in the masses were also visible. Intense positiCardiac tumours in children are rare. It is difficult to
estimate the real prevalence because the available data
are restricted to autopsy and case records from leading
paediatric centres. It is believed that they constitute less
than 0.1% of all neoplasms and occur with an incidence
of 0.0017 to 0.28 in autopsy records [5,6].
Among 27.640 patients examined echocardiographi-
cally in 5-year periods, the incidence of cardiac tumours
increased: 0.06% (1980–1984), 0.22% (1985–1989) and
0.32% (1990–1995) of all the subjects [7].
Benign lesions usually predominate, making up more
than 90% of all paediatric tumours: rhabdomyomas are
the most frequent cardiac tumours in children (45-50%),
followed by fibromas (25-30%), mixomas, lipomas, tera-
tomas, hemangiomas, etc. [8-10]. The most common
malignant primary tumours are angiosarcoma, fibrosar-
coma, lymphosarcoma, and giant cell sarcoma [2]. Sec-
ondary cardiac neoplasms in the paediatric population
include non-Hodgkin lymphoma, leukemic infiltration,
and neuroblastoma.
Rhabdomyoma is the most common cardiac tumour in
paediatric patients. It usually presents during the first
few days after birth, but it can be diagnosed in the third
trimester of pregnancy.
Foetal cardiac rhabdomyoma accounts for less than
10% of foetal demise cases [11]. Cardiac rhabdomyomas
are benign from the cardiovascular standpoint in most
affected foetuses. They are associated strongly with tu-
berous sclerosis, a hereditary disorder characterized by
hamartomas in various organs, epilepsy, mental defi-
ciency, and sebaceous adenomas [12]. Rhabdomyoma
(especially multiple) affects about 50% of childrenmoral mass from the surrounding regular parenchyma. Small residues
ve reaction for antibodies anti-Desmin (B), anti-Actin (C-D).
Figure 3 Microscopic findings. (A-B) Intense positive reaction of the tumoral fibers for antibodies anti-CD34 and anti-Vimentin (C-D).
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patients with rhabdomyoma have or will develop tuber-
ous sclerosis. The exceptional patient is one with a soli-
tary, single rhabdomyoma who does not have or develop
tuberous sclerosis.
Over 90% of rhabdomyomas are multiple and occur
with approximately equal frequency in both ventricles.
The atrium is involved in fewer than 30% of patients.
Macroscopically, these tumours are firm, grey, and
nodular and tend to project into the ventricular cavity.
Microscopy shows myocytes of twice normal size filled
with glycogen and containing hyperchromatic nuclei and
eosinophilic-staining cytoplasmic granules. Scattered
bundles of myofibrils can be seen within cells by elec-
tron microscopy.
These tumours grow during the second half of preg-
nancy; they have the tendency to diminish or even com-
pletely disappear spontaneously after birth. Many will
disappear entirely; alternatively, the tumour size remains
constant as the heart grows, which has much the same
effect [13,14].
In the majority of cases cardiac rhabdomyomas are
clinically completely silent and have a benign course.
They may be incidentally discovered during an echocar-
diogram, but they also may cause cardiac dysfunctions
requiring medical and/or surgical intervention. During
foetal life and the early neonatal period, life-threatening
conditions, mostly due to arrhythmias, cardiac failure or
obstruction, do occur on rare occasions [15]. How threa-
tening rhabdomyomas are, in terms of clinical presenta-
tion and presence of hemodynamic complications,
depends on their size, location and number of lesions.
Although the behaviour of cardiac rhabdomyoma isbenign, its positioning within critical areas in the heart
can lead to lethal arrhythmias and chamber obstruction.
The most common presentation is heart failure caused
by tumour obstruction of cardiac chambers or valvular
orifice flow. Clinical findings may mimic valvular or sub-
valvular stenosis. Arrhythmias, particularly ventricular
tachycardia and sudden death, may be a presenting
symptom [16,17]. Atrial tumours may produce atrial
arrhythmias. The mechanism of their causing sudden
death is likely rhythm disturbances, particularly the
Wolff-Parkinson-White ventricular pre-excitation syn-
drome [17]. The conduction abnormalities and the
arrhythmia are thought to be due to the tumoral mass,
which may lead to degeneration of the cardiac conduc-
tion system and compose a substrate for re-entrant
arrhythmia, e.g. the development of atrioventricular
block and ventricular arrhythmia. Large tumoral mass in
the myocardial region, accompanied with arrhythmia,
revealed that the neoplastic mass could affected the
common bundle of His, in addition to the ordinary myo-
cardium, being causative of circulatory failure [18,19].
Although most cardiac rhabdomyomas have a rela-
tively benign perinatal course, the long-term prognosis is
determined by the neurological manifestations asso-
ciated with tuberous sclerosis.
Rhabdomyoma may be detected prenatally by ultra-
sound in the third trimester of pregnancy. However, a
large number is diagnosed in infancy. The diagnosis is
suggested by clinical features of tuberous sclerosis and is
made by echocardiography. Heart echocardiography, CT
and MRI are the major non-invasive diagnostic proce-
dures, while angiography is used in selected cases, due
to its invasive nature. Even though ECG is not specific
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ence of rhythm disorders, while a chest X-ray may show
an enlarged heart silhouette or abnormal cardiac
contours.
Therapeutic strategies should be individualised: the
total resection is not the only therapeutic aim, in fact,
the restoration of the regular heart function may be of
primary relevance. Antiarrhythmic agents successfully
control the clinical and electrophysiological conditions,
while surgery is indicated in children with significant
clinical symptoms. Benign cardiac tumours in childhood
have an excellent prognosis when completely excised
and have a good short-term prognosis even when exci-
sion is incomplete. Asymptomatic patients require any-
way a close follow-up [20].
This report outlines the importance of an early diag-
nosis of cardiac tumours: when the prenatal and/or neo-
natal diagnosis of rhabdomyoma is made, an appropriate
planning and an accurate follow-up may be performed
to formulate individualised therapeutic strategies, im-
proving in this way the clinical outcome and, eventually,
anticipating the development of tuberous sclerosis.
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